The use of low-dose IV haloperidol is not associated with QTc prolongation: post hoc analysis of a randomized, placebo-controlled trial

被引：12

作者：

Duprey, Matthew S. ^{[1
]}

Al-Qadheeb, Nada ^{[2
]}

Roberts, Russel ^{[3
]}

Skrobik, Yoanna ^{[4
]}

Schumaker, Greg ^{[5
]}

Devlin, John W. ^{[1
,5
]}

机构：

[1] Northeastern Univ, Sch Pharm, 360 Huntington Ave,TF R218, Boston, MA 02115 USA

[2] Hafer Albatin Cent Hosp, Dept Crit Care, Riyadh, Saudi Arabia

[3] Massachusetts Gen Hosp, Dept Pharm, Boston, MA 02114 USA

[4] McGill Univ, Div Crit Care, Ctr Hlth, Montreal, PQ, Canada

[5] Tufts Med Ctr, Div Pulm Crit Care & Sleep Med, Boston, MA USA

来源：

INTENSIVE CARE MEDICINE | 2016年 / 42卷 / 11期

关键词：

CRITICALLY-ILL PATIENTS; TORSADES-DE-POINTES; INTRAVENOUS-HALOPERIDOL; DELIRIUM;

D O I：

10.1007/s00134-016-4512-3

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：1818 / 1819

页数：2

共 5 条

[1] Preventing ICU Subsyndromal Delirium Conversion to Delirium With Low-Dose IV Haloperidol: A Double-Blind, Placebo-Controlled Pilot Study* [J].

Al-Qadheeb, Nada S. ;

Skrobik, Yoanna ;

Schumaker, Greg ;

Pacheco, Manuel N. ;

Roberts, Russel J. ;

Ruthazer, Robin R. ;

Devlin, John W. .

CRITICAL CARE MEDICINE, 2016, 44 (03) :583-591

[2]

Drew BJ, 2010, J AM COLL CARDIOL, V55, P934, DOI [10.1016/j.jacc.2010.01.001, 10.1161/CIRCULATIONAHA.109.192704]

[3] Torsades de pointes associated with intravenous haloperidol in critically ill patients [J].

Sharma, ND ;

Rosman, HS ;

Padhi, ID ;

Tisdale, JE .

AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (02) :238-240

[4] Antipsychotic use and diagnosis of delirium in the intensive care unit [J].

Swan, Joshua T. ;

Fitousis, Kalliopi ;

Hall, Jeffrey B. ;

Todd, S. Rob ;

Turner, Krista L. .

CRITICAL CARE, 2012, 16 (03)

[5] The effect of intravenous haloperidol on QT interval dispersion in critically ill patients: Comparison with QT interval prolongation for assessment of risk of Torsades de Pointes [J].

Tisdale, JE ;

Rasty, S ;

Padhi, ID ;

Sharma, ND ;

Rosman, H .

JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 41 (12) :1310-1318

← 1 →